Cancer Research: Oncolytic Viruses Have Great Potential for the Treatment of Cancers

Viruses the most feared infectious agents can also become allies against cancer according to new research. This was demonstrated by a group of scientists exploring current research opportunities that combine traditional therapies and genetic engineering.


HSV1. Image Courtesy of Thomas Splettstoesser

Read Also: Scientists Are Now Using Viruses to Treat Cancers And, Other Diseases

Oncolytic viruses, literally “cancer-killing viruses,” have been around for more than a century thanks to the first described case in 1904, when a patient suffering from myeloid leukemia went into remission after a suspected flu infection. Oncolytic viruses have the advantage of preferentially multiplying in tumor cells and leading to their regression by lysing the cells and stimulating the tumor immune response.

Oncolytic viruses Properties

Cancer cells have very specific properties. They produce large amounts of nucleotides for rapid reproduction, form a network of blood vessels for oxygenation, and have the ability to divert the immune response by not responding to certain cytokines (interferon type 1). Moreover, they confuse the immune system by producing proteins on their surface that can inhibit cytotoxic cells. This last point, incidentally, is a cornerstone of research into immunotherapies used to treat some cancers.

Read Also: Chronic Infections and Cancers Can Lead To Functional Exhaustion of T Cells

It is these different properties that will be exploited in the use of oncolytic viruses. To be a suitable candidate, the virus used must have little or no toxicity to normal tissue, be immunogenic and preferentially target cancer cells.

Thanks to genetic engineering, it is now possible to delete viral genes (knock-out) or add transgenes (knock-in). These techniques make it possible to develop transgenic viruses that will preferentially multiply in malignant cells. Deleting the gene for thymine kinase, which forces the virus to infect cells with a high nucleotide production capacity, and adding a gene encoding cytokines that stimulate anti-tumor immune activity are just a few examples.

Read Also: Crazy Cat Lady Parasite Combined with Immunotherapy Improves Response in Some Cancers

Combination therapies

Although using oncolytic viruses for the treatment of cancer has been explored for several years, their use is still limited because of many unknowns. For instance, the antiviral pathways of tumor cells are still unknown and there are physical barriers that limit the penetration of the viruses into tumor cells. In addition, they can be destroyed by antibodies circulating in the body. However, a recent analysis showed that they can be valuable allies when combined with other conventional treatments (radiotherapy, chemotherapy) or more innovative treatments such as immunotherapy with checkpoint inhibition (a promising strategy, but one that only works in 10 to 20% of cases). Genetic manipulation applied to oncolytic viruses makes them complementary armament vectors thanks to their ability to induce cell lysis and immune stimulation.

Read Also: NIH: Fecal Transplant Boosts Immunotherapy Response in People with Advanced Melanoma

Currently, only a few oncolytic viruses are licensed worldwide. Amongst them is a modified form of the Herpes simplex virus (HSV-1) which has been approved for the treatment of inoperable metastatic melanoma.  Another approved oncolytic virus is the Myxoma virus which causes myxomatosis in rabbits. It was chosen because it has a long genome that can contain stable modifications and because it is harmless to humans.


Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy

Articles you may like:

Complications of Tooth Extractions and How to Avoid Them

Artificial Intelligence VS the Pandemic: Fighting COVID-19 Effectively

Study Reveals The Crucial Role Of Immunotherapy In Lung Fibrosis

Researchers Scan Single-Molecules of Peptides with Nanopore Sequencing Technology

Combination of Immunotherapy Agents Promotes Long-Term Cancer Remission in Study

Mechanism Developed to Manipulate Oxidative Stress Using Glutathione Transporter Could Destroy Cancer Cells

Hearing Loss: MIT Study Shows That COVID-19 Also Attacks Our Ears

Vaccinated People Can Still Contract and Transmit the Delta Variant According to Imperial College Study

Finnish Scientists Produce Lab-Grown Coffee That Tastes Like the Real Thing

What the Rest of the World Can Learn from the Chinese Response to the Pandemic

7 Diseases That Are Transmitted through Tick Bites That You Should Be Aware Of

Burnout Latest Facts: Causes, Risk Factors, Symptoms, Treatment and How to Protect Yourself at Work?

HGH Dosages Currently Being Used for Anti Aging, Weight Loss, and Bodybuilding

Health Insurance: Why It Is Important to Be Insured All the Time

How to Grow Taller

Chronic Pain Can Lead To Anxiety and Depression According to NeuRA Study

Giving Employees the Possibility to Take a 30 Minute Nap Improves Productivity

Global Food Security: Climate Change Is Likely to Cause More Plant Diseases Which Will Affect Crop Yield

HGH Benefits

Vaccination rates below 90% Could Paradoxically Promote the Emergence of Resistant Variants

Nightmare Scenario: Could the Current Poorly Implemented Vaccination Campaign Lead to More Deadly SARS-CoV-2 Strains

Possible Causes of the Sudden Fall In COVID-19 Infections in the UK and Europe

Moderna and Pfizer’s mRNA Vaccines Do Not Make Straight Men Gay

Gilmore Health

Coronavirus: The Real and False Side Effects of COVID-19 Vaccines


Genf20 Plus

Growth Factor Plus Reviews




Want to Stay Informed?

Join the Gilmore Health News Newsletter!

Want to live your best life?

Get the Gilmore Health Weekly newsletter for health tips, wellness updates and more.

By clicking "Subscribe," I agree to the Gilmore Health and . I also agree to receive emails from Gilmore Health and I understand that I may opt out of Gilmore Health subscriptions at any time.